HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


NBTY Expects Growth Opportunities From Economic Slump, New Regulations

This article was originally published in The Tan Sheet

Executive Summary

NBTY Chairman and CEO Scott Rudolph anticipates the current economic downturn combined with new regulatory and legislative requirements will lead to opportunities for new acquisitions

You may also be interested in...

NBTY’s Ester-C Plans Under Wraps But Shining Through; Firms Strategize

NOW Foods is developing a "replacement Ester-C product" with the goal of selling it as a branded ingredient to other firms, National Sales Manager Dan Richard told "The Tan Sheet.

NBTY Broadens Health Food Store Presence With Solgar, SISU Acquisitions

NBTY is making inroads into the high-end health food store market with the acquisition of Wyeth's Solgar vitamin business

Avoiding GMP “Showstoppers” Keeps Manufacturers Off FDA’s “Radar”

Compliance consultants warn that certain dietary supplement good manufacturing practices violations are inspection "showstoppers" and will draw agency enforcement


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts